Woodcock's return to CDER may improve drug approval climate

05/19/2008 | RPM Report (free registration), The

Some analysts say Janet Woodcock's return to head the Center for Drug Evaluation & Research is having a positive impact on the drug approval environment at the FDA, citing more green lights for tough product approvals in recent months. Woodcock says there haven't been any changes to approval standards, but says that she has been involved in some recent approval decisions, particularly those using risk evaluation and mitigation strategies.

View Full Article in:

RPM Report (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ